Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for PROPYLENGLYKOLHALTIGE PEPTIDFORMULIERUNGEN, DIE ZUR HERSTELLUNG UND ZUM EINSATZ IN EINSPRITZVORRICHTUNGEN OPTIMAL SIND
Details for 2017196501
Up to date per 09.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2017196501
Title / Product Name
PROPYLENGLYKOLHALTIGE PEPTIDFORMULIERUNGEN, DIE ZUR HERSTELLUNG UND ZUM EINSATZ IN EINSPRITZVORRICHTUNGEN OPTIMAL SIND
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2017196501
EP Publication Number
3300721
E-Number
1103586
Language
EN
PCT Number
-
Publication Date
04.04.2018 A
06.03.2019 B1
Registration Date
06.03.2019
AT Publication Date
15.03.2019
Application Date
18.11.2004
Registration Number
-
Priorities
20.11.2003
DK
200301719
IPC
A61K 9/00 20060101AFI20180725BHEP
Maximum Duration of Protection
18.11.2024
Owner
Novo Nordisk A/S
Novo Allé
2880 Bagsværd
DK
Representative
No representatives present
Inventor
Bonde, Claude
Novo Nordisk A/S Novo Allé
2880 Bagsværd
DK
Engelund, Dorthe Kot
Novo Nordisk A/S Novo Allé
2880 Bagsværd
DK
Pedersen, Tina Bjeldskov
Novo Nordisk A/S Novo Allé
2880 Bagsværd
DK